DH (Definitive Healthcare) Risk Assessment


DH Definitive Healthcare Corp DH
51 GF Score
Price $0.90
GF Value $4.44
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Definitive Healthcare Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Definitive Healthcare is: High Risk: High uncertainty.

Definitive Healthcare  (NAS:DH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Definitive Healthcare Risk Assessment Related Terms

DH vs DRIO, CCLD, OPRX: Risk Assessment Comparison

For the Health Information Services subindustry, Definitive Healthcare's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Definitive Healthcare Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Risk Assessment falls into.


DH
51GF Score
Definitive Healthcare Corp DH
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Definitive Healthcare (DH) Overvalued in 2026?

Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued. The current stock price of $0.90 is trading 79.7% below its estimated GF Value™ of $4.44. GuruFocus considers Definitive Healthcare to be Possible Value Trap.

Key valuation signals for DH:

  • Risk Assessment:
  • GF Value™: $4.44 vs. price of $0.90 (79.7% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Definitive Healthcare Business Description

Address 492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score

Get the complete analysis for DH

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price
$4.44
GF Value